133 related articles for article (PubMed ID: 24677401)
1. How do estrogens control lymphoma?
Roemer K; Pfreundschuh M
Blood; 2014 Mar; 123(13):1980-1. PubMed ID: 24677401
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists.
Yakimchuk K; Hasni MS; Guan J; Chao MP; Sander B; Okret S
Blood; 2014 Mar; 123(13):2054-61. PubMed ID: 24470591
[TBL] [Abstract][Full Text] [Related]
3. Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo.
Yakimchuk K; Iravani M; Hasni MS; Rhönnstad P; Nilsson S; Jondal M; Okret S
Leukemia; 2011 Jul; 25(7):1103-10. PubMed ID: 21502954
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor β selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells.
Zhang B; Zhang CG; Ji LH; Zhao G; Wu ZY
J Gastroenterol Hepatol; 2018 Mar; 33(3):747-755. PubMed ID: 28884481
[TBL] [Abstract][Full Text] [Related]
5. Adult female wildtype, but not oestrogen receptor beta knockout, mice have decreased depression-like behaviour during pro-oestrus and following administration of oestradiol or diarylpropionitrile.
Walf AA; Koonce CJ; Frye CA
J Psychopharmacol; 2009 Jun; 23(4):442-50. PubMed ID: 18562442
[TBL] [Abstract][Full Text] [Related]
6. The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways.
Mancuso M; Leonardi S; Giardullo P; Pasquali E; Borra F; Stefano ID; Prisco MG; Tanori M; Scambia G; Majo VD; Pazzaglia S; Saran A; Gallo D
Cancer Lett; 2011 Sep; 308(2):197-202. PubMed ID: 21636213
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor β ligation inhibits Hodgkin lymphoma growth by inducing autophagy.
Pierdominici M; Maselli A; Locatelli SL; Ciarlo L; Careddu G; Patrizio M; Ascione B; Tinari A; Carlo-Stella C; Malorni W; Matarrese P; Ortona E
Oncotarget; 2017 Jan; 8(5):8522-8535. PubMed ID: 28052027
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy.
Nair HB; Kirma NB; Ganapathy M; Vadlamudi RK; Tekmal RR
Steroids; 2011 Jul; 76(8):792-6. PubMed ID: 21477609
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic strategies will be a revolution in lymphoma?
Paydas S
Leuk Res; 2010 Apr; 34(4):552. PubMed ID: 19819016
[No Abstract] [Full Text] [Related]
10. The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line.
Motylewska E; Stasikowska O; Mełeń-Mucha G
Cancer Lett; 2009 Apr; 276(1):68-73. PubMed ID: 19101081
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen receptor ERα and ERβ agonists ameliorate oxidative brain injury and improve memory dysfunction in rats with an epileptic seizure.
Koyuncuoğlu T; Arabacı Tamer S; Erzik C; Karagöz A; Akakın D; Yüksel M; Yeğen BÇ
Exp Physiol; 2019 Dec; 104(12):1911-1928. PubMed ID: 31608530
[TBL] [Abstract][Full Text] [Related]
12. Long-term selective estrogen receptor-beta agonist treatment modulates gene expression in bone and bone marrow of ovariectomized rats.
Balla B; Sárvári M; Kósa JP; Kocsis-Deák B; Tobiás B; Árvai K; Takács I; Podani J; Liposits Z; Lakatos P
J Steroid Biochem Mol Biol; 2019 Apr; 188():185-194. PubMed ID: 30685384
[TBL] [Abstract][Full Text] [Related]
13. Salutary effects of estrogen receptor-beta agonist on lung injury after trauma-hemorrhage.
Yu HP; Hsieh YC; Suzuki T; Shimizu T; Choudhry MA; Schwacha MG; Chaudry IH
Am J Physiol Lung Cell Mol Physiol; 2006 May; 290(5):L1004-9. PubMed ID: 16361351
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-β regulates human tryptophan hydroxylase-2 through an estrogen response element in the 5' untranslated region.
Hiroi R; Handa RJ
J Neurochem; 2013 Nov; 127(4):487-95. PubMed ID: 24033289
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress.
Weiser MJ; Wu TJ; Handa RJ
Endocrinology; 2009 Apr; 150(4):1817-25. PubMed ID: 19074580
[TBL] [Abstract][Full Text] [Related]
16. Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists.
Paruthiyil S; Cvoro A; Zhao X; Wu Z; Sui Y; Staub RE; Baggett S; Herber CB; Griffin C; Tagliaferri M; Harris HA; Cohen I; Bjeldanes LF; Speed TP; Schaufele F; Leitman DC
PLoS One; 2009 Jul; 4(7):e6271. PubMed ID: 19609440
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-β signaling modulates epithelial barrier function.
Looijer-van Langen M; Hotte N; Dieleman LA; Albert E; Mulder C; Madsen KL
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G621-6. PubMed ID: 21252046
[TBL] [Abstract][Full Text] [Related]
18. Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells.
Sotoca AM; van den Berg H; Vervoort J; van der Saag P; Ström A; Gustafsson JA; Rietjens I; Murk AJ
Toxicol Sci; 2008 Oct; 105(2):303-11. PubMed ID: 18644836
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
Setlur SR; Mertz KD; Hoshida Y; Demichelis F; Lupien M; Perner S; Sboner A; Pawitan Y; Andrén O; Johnson LA; Tang J; Adami HO; Calza S; Chinnaiyan AM; Rhodes D; Tomlins S; Fall K; Mucci LA; Kantoff PW; Stampfer MJ; Andersson SO; Varenhorst E; Johansson JE; Brown M; Golub TR; Rubin MA
J Natl Cancer Inst; 2008 Jun; 100(11):815-25. PubMed ID: 18505969
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic effects and neuroanatomical targets of estrogen receptor-β (ERβ) activation by a selective ERβ agonist in female mice.
Oyola MG; Portillo W; Reyna A; Foradori CD; Kudwa A; Hinds L; Handa RJ; Mani SK
Endocrinology; 2012 Feb; 153(2):837-46. PubMed ID: 22186418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
